DK0060336014
DK0060336014
Novonesis (Novozymes A/S) B
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 202.91B EUR | 192.51B EUR | 178.33B EUR | 190B EUR |
Enterprise Value | 206.08B EUR | 195.27B EUR | 181.22B EUR | 189.72B EUR |
Valuation Multiples | ||||
Trailing P/E | 42.82x | 390.02x | 388.78x | 426.39x |
Forward P/E | 24.23x | -- | -- | -- |
Price to Sales | 47.22x | 59.56x | 56.9x | 61.43x |
Price to Book | 2.44x | 17.26x | 16.33x | 17.5x |
EV/Revenue | 47.96x | 60.42x | 57.82x | 61.35x |
EV/EBITDA | 128.04x | 291.28x | 280.05x | 290.45x |
Price to FCF (P/FCF) | 279.22x | 471.15x | 431.38x | 486.43x |
EV/FCF | 283.58x | 477.91x | 438.36x | 485.73x |
FCF Yield | 0.36% | 0.21% | 0.23% | 0.21% |